Denmark’s Novo-Fueled Economy Faces Lower Growth, Watchdog Says

Denmark's economy faces slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses momentum, the country's financial watchdog said. The industry is expected to settle into a pace more in line with the rest of the economy, tempering the recent surge that had been driven by the drugmaker's weight-loss and diabetes treatments.